يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Hamanishi, Kristen A."', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)

    المؤلفون: Penrose, Kerri J., Parikh, Urvi M., Hamanishi, Kristen A., Else, Laura, Back, David, Boffito, Marta, Jackson, Akil, Mellors, John W.

    المصدر: The Journal of Infectious Diseases, 2016 Mar . 213(6), 1013-1017.

    الوصول الحر: http://www.jstor.org/stable/24716577Test


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

    المؤلفون: Penrose, Kerri J, Brumme, Chanson J, Scoulos-Hanson, Maritsa, Hamanishi, Kristen, Gordon, Kelley, Viana, Raquel V, Wallis, Carole L, Harrigan, P Richard, Mellors, John W, Parikh, Urvi M

    المساهمون: Bill and Melinda Gates Foundation

    المصدر: Antiviral Chemistry and Chemotherapy ; volume 26, page 204020661876298 ; ISSN 2040-2066 2040-2066

    مصطلحات موضوعية: General Medicine

    الإتاحة: https://doi.org/10.1177/2040206618762985Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

    المؤلفون: Penrose, Kerri J., Wallis, Carole L., Brumme, Chanson J., Hamanishi, Kristen A., Gordon, Kelley C., Viana, Raquel V., Harrigan, P. Richard, Mellors, John W., Parikh, Urvi M.

    المساهمون: Bill and Melinda Gates Foundation

    المصدر: Antimicrobial Agents and Chemotherapy ; volume 61, issue 2 ; ISSN 0066-4804 1098-6596

    الإتاحة: https://doi.org/10.1128/aac.01805-16Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)

    المؤلفون: Penrose, Kerri J., Parikh, Urvi M., Hamanishi, Kristen A., Else, Laura, Back, David, Boffito, Marta, Jackson, Akil, Mellors, John W.

    المساهمون: Bill and Melinda Gates Foundation

    المصدر: Journal of Infectious Diseases ; volume 213, issue 6, page 1013-1017 ; ISSN 0022-1899 1537-6613

    مصطلحات موضوعية: Infectious Diseases, Immunology and Allergy

    الإتاحة: https://doi.org/10.1093/infdis/jiv528Test
    http://academic.oup.com/jid/article-pdf/213/6/1013/17411273/jiv528.pdfTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT 040 Trial

    المؤلفون: Penrose, Kerri J., Parikh, Urvi M., Hamanishi, Kristen A., Panousis, Constantinos, Else, Laura, Back, David, Boffito, Marta, Jackson, Akil, Mellors, John W.

    المصدر: AIDS Research and Human Retroviruses ; volume 30, issue S1, page A69-A69 ; ISSN 0889-2229 1931-8405

    مصطلحات موضوعية: Infectious Diseases, Virology, Immunology

    الإتاحة: https://doi.org/10.1089/aid.2014.5127.abstractTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Supplementary table - Supplemental material for Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

    المؤلفون: Penrose, Kerri J, Chanson J Brumme, Maritsa Scoulos-Hanson, Hamanishi, Kristen, Gordon, Kelley, Viana, Raquel V, Wallis, Carole L, P Richard Harrigan, Mellors, John W, Parikh, Urvi M

    مصطلحات موضوعية: FOS: Clinical medicine, FOS: Biological sciences, Cell Biology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 69999 Biological Sciences not elsewhere classified, 3. Good health

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8799b4be5c2cf720f0d474ff445cfe67Test


    أضف إلى المفضلة
  7. 7
    Supplementary table - Supplemental material for Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

    المؤلفون: Penrose, Kerri J, Chanson J Brumme, Maritsa Scoulos-Hanson, Hamanishi, Kristen, Gordon, Kelley, Viana, Raquel V, Wallis, Carole L, P Richard Harrigan, Mellors, John W, Parikh, Urvi M

    مصطلحات موضوعية: FOS: Clinical medicine, FOS: Biological sciences, Cell Biology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 69999 Biological Sciences not elsewhere classified, 3. Good health

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::80826fac2dec783836ad3d2fc8209799Test


    أضف إلى المفضلة
  8. 8
    دورية
    Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

    المؤلفون: Penrose, Kerri J., Wallis, Carole L., Brumme, Chanson J., Hamanishi, Kristen A., Gordon, Kelley C., Viana, Raquel V., Harrigan, P. Richard, Mellors, John W., Parikh, Urvi M.

    المصدر: Antimicrobial Agents and Chemotherapy; November 2016, Vol. 61 Issue: 2

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT 040 Trial.

    المؤلفون: Parikh, Urvi M., Hamanishi, Kristen A., Panousis, Constantinos, Else, Laura, Back, David, Boffito, Marta, Jackson, Akil, Mellors, John W.

    المصدر: AIDS Research & Human Retroviruses; Oct2014 Supplement, Vol. 30, pA69-A69, 1p


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث